http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026308-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68425f8490b4e570202f01e084a1fbe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4e76712cb3b510f90b9c4825d1c285c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_592c0b96e9fb9d57e50ca8cbf07c9a14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d778b934583baebe66daba95de3b36aa
publicationDate 2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004026308-A1
titleOfInvention Sustained release compound of acetamidophenol and tramadol
abstract The present invention relates to a sustained release preparation containing 100-1000mg acetamidophenol and 15-150mg tramadol in its unit dosage. The unit dosage includes (1)fast release part cantaining 25­75% of total active principle; (2) sustained release part containing (a) 25­75% of total active principle; and (b) 6-50% of colloidal polymer, as the prepation's total weight; and optionally containing (c) 5-40% of enteric coating. In first hour, said prepation's release amount is 25-60% of the total realse amount, and in first four hours, the release amount is not less than 80%, accoding to USP dissolution test II, under the condition of 50rpm.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015044952-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130137720-A
priorityDate 2002-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5336691-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6294195-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820522-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129321892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226541903

Total number of triples: 39.